ABSI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Absci Corp (ABSI) is not a strong buy for a beginner investor with a long-term horizon and $50,000-$100,000 available for investment. The technical indicators are mixed, with bearish moving averages and neutral RSI. The options data indicates low put-call ratios, suggesting bullish sentiment, but the company's financial performance is weak, with significant revenue decline and negative earnings. Analysts have downgraded the stock, and hedge funds are selling heavily. Without strong positive catalysts or proprietary trading signals, holding off on this investment is recommended.
The technical indicators show a mixed picture. The MACD is positive and expanding, suggesting bullish momentum, but the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). RSI is neutral at 61.754, and the stock is trading near its resistance level of 2.796. The stock has a 60% chance of a slight gain (1.86%) in the next day but a potential decline (-2.2%) in the next week.
The MACD histogram is positive and expanding, and the options data shows a bullish sentiment with low put-call ratios.
Hedge funds are selling heavily, with a 1029.38% increase in selling activity last quarter. Analysts have downgraded the stock, citing increased risk and reduced visibility of near-term execution. Financial performance is weak, with a 77.78% YoY revenue decline and negative EPS. No recent news or congress trading data to support a positive outlook.
In Q3 2025, revenue dropped significantly by 77.78% YoY to $378,000. Net income improved slightly but remains negative at -$28.71M. EPS decreased by 16.67% YoY to -0.2. Gross margin remained flat at 100%. Overall, the financial performance is weak and does not support a strong buy case.
Recent analyst activity includes a downgrade by Morgan Stanley to Equal Weight with a reduced price target of $4.32 (down from $5.80), citing increased risk and reduced visibility. On the other hand, H.C. Wainwright raised the price target to $8 from $7, expressing confidence in the ABS-201 program. However, the overall sentiment leans negative due to the downgrade and risk concerns.
